Obesity is an important factor predisposing to type 2 diabetes mellitus, especially for postmenopausal women. Experimental studies provided evidences that leptin, cholecystokinin (CCK), galanin (GAL), neuropeptide Y (NPY) and insulin are involved in feeding behaviour. The aim of the study was to evaluate their possible relationships in obese and diabetic women.
Introduction
Obesity is an important factor predisposing to type 2 diabetes mellitus, especially for postmenopausal women. Experimental studies provided evidences that leptin, cholecystokinin (CCK), galanin (GAL), neuropeptide Y (NPY) and insulin are involved in feeding behaviour. In contrast to insulin, the role of CCK, GAL, NPY and leptin in diabetic patients remains poorly understood. The aim of this study was to evaluate possible relationships of insulin, CCK, GAL, NPY and leptin in obese and diabetic female objects.
Material
Three groups of postmenopausal women (FSH b 30 mIUaml) were evaluated: 8 diabetic (mean age 56.6 AE 6.9 y, BMI 29.8 AE 5.3 kgam 2 ), 10 obese (mean age 49.6 AE 5.4 y, BMI 36.0 AE 3.7 kgam 2 ) and 12 nondiabetic controls (mean age 52.7 AE 3.5 y, BMI 27.3 AE 1.9 kgam 2 ). All diabetic subjects were diagnosed as type 2 diabetes mellitus, treated orally (sulphonyloureas) and well equilibrated (hemoglobin A 1c`8 .0%).
Methods
For each patient body mass index (BMI) and waist-tohip circumference ratio (WHR) were available. Blood samples were collected from cubital vein at 0800 h, 12 h after an overnight fast, taken on ice, immediately centrifuged in cool conditions ( 4 C), frozen (at 770 C) and stored until assays. Plasma concentrations of leptin were determined using recombinant human leptin as a standard (Linco, USA). CCK, GAL and NPY were measured by speci®c RIA kits (Peninsula, USA) after plasma extraction on reverse-phase mini columns. Insulin was measured using commercial MEIA kit (Abbott). Informed consent was obtained from each participant of the study. Statistical analysis was performed using STATISTICA software (StatSoft). Correlations were evaluated using linear regression methods. The level of signi®cance was set at P`0.05.
Results
There were no signi®cant differences in plasma hormones levels in diabetic group, except higher NPY levels (190.1AE 85.4 vs 120.4AE 36.6 pgaml), in comparison to controls (Figure 1) . In obese subjects, mean leptin plasma level was signi®cantly higher in comparison to controls (32.9AE 9.2 vs 18.9AE 9.1 ngaml).
In diabetic subjects positive correlations were found between: CCK and leptin (r 0.8295; P 0.011), CCK and insulin (r 0.7832; P 0.022), leptin and insulin (r 0.9302; P 0.001). In obese subjects a positive correlation between WHR and GAL (r 0.6624; P 0.037) and a negative between GAL and insulin (r 7 0.6795; P 0.031) were found. In controls positive correlations were found between WHR and CCK (r 0.6412; P 0.025), GAL and insulin (r 0.630; P 0.028) and negative between CCK and NPY (r 7 0.6505; P 0.022).
Discussion
Elevated NPY levels in diabetic premenopausal women have been described previously by Baranowska et al. 1 In contrast, our diabetic group consisted of exclusively postmenopausal women. Signi®cantly higher leptin levels in obese subjects follow results of many previous studies showing that elevation of serum leptin concentrations is closely correlated with the percentage of body fat. 2 The positive correlation between leptin and insulin in our diabetic patients re¯ects resistance to insulin, and has been previously widely described. 3 The feeling of satiety in rats is stimulated by CCK and estradiol. 4 Our previous study revealed a positive correlation between CCK and estradiol in women. 5 Therefore, in postmenopausal women, estradiol de®-ciency can contribute to altered sensitivity to CCK.
In summary, our results, ie higher NPY levels in diabetic women and positive correlation of CCK with leptin and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus. However, estimations of peptides were performed in plasma and re¯ect not only central but also peripheral secretion. Estimation of peptides concentration in central nervous system was impossible for ethical reasons.
